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ABSTRACT  
   
This study examined whether cognitive behavioral therapy and mindfulness interventions 
affect positive (PA) and negative affect (NA) reports for patients with rheumatoid arthritis (RA) 
before, during, and after stress induction.  The study also investigated the effects of a history of 
recurrent depression on intervention effects and testing effects due to the Solomon-6 study design 
utilized.  The 144 RA patients were assessed for a history of major depressive episodes by 
diagnostic interview and half of the participants completed a laboratory study before the 
intervention began.  The RA patients were randomly assigned to 1 of 3 treatments: cognitive 
behavioral therapy for pain (P), mindfulness meditation and emotion regulation therapy (M), or 
education only attention control group (E).  Upon completion of the intervention, 128 of the RA 
patients participated in a laboratory session designed to induce stress in which they were asked to 
report on their PA and NA throughout the laboratory study.  Patients in the M group exhibited  
dampened negative and positive affective reactivity to stress, and sustained PA at recovery, 
compared to the P and E groups.  PA increased in response to induced stress for all groups, 
indicating an “emotional immune response.”  History of recurrent depression increased negative 
affective reactivity, but did not predict reports of PA.  RA patients who underwent a pre-
intervention laboratory study showed less reactivity to stressors for both NA and PA during the 
post-intervention laboratory study.  The M intervention demonstrated dampened emotional 
reactions to stress and lessened loss of PA after stress induction, displaying active emotion 
regulation in comparison to the other groups.  These findings provide additional information about 
the effects of mindfulness on the dynamics of affect and adaptation to stress in chronic pain 
patients. 
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Chapter 1 
INTRODUCTION 
 The stress response is a normal reaction to stimuli in the environment.  Our reactions to 
potentially harmful stressors are adaptive, and allow us to engage in self-preservation behaviors.  
In the face of environmental or physiological challenge, activation of the autonomic sympathetic 
nervous system prepares the organism to engage in these self-preservation behaviors, while 
activation of the parasympathetic nervous system returns the organism’s systems to homeostasis.  
These systems work in tandem.  A life of chronic stress, such as that seen in chronic illness, can 
disrupt the equalizing tendency of these opponent processes and contribute to poorer mental and 
physical health outcomes as well as make it difficult to sustain a positive, meaningful life (Davis, 
Zautra, & Smith, 2004).  Individuals with rheumatoid arthritis (RA); a chronic, systemic, and 
progressive autoimmune disease characterized by inflammation of the joint lining and chronic 
pain; endure daily stresses along with the pain and uncertainty of living with a chronic ailment. 
 An examination of these daily experiences allows us to gain a clearer picture of how the 
ebb and flow of stress relate to the physical health of an individual with RA.  In a review of 27 
independent studies stress from minor life events was related to increased disease activity 
(Herrmann, Scholmerich, & Straub, 2000).  Zautra and colleagues (1997) found that for RA 
patients experiencing a stressful episode, increases in the number of stressful interpersonal events 
in one week were associated with increased patient-reported joint tenderness, clinician’s global 
rating of disease activity, and increased immune activity in the same and subsequent weeks.  
Interleukin-6 (IL-6), a proinflammatory cytokine associated with the acute inflammatory response, 
has been implicated as a potential mediator for RA disease activity.  Elevated circulating levels of 
IL-6, indicative of systemic inflammation, have been found in RA patients undergoing stressful 
circumstances: chronic interpersonal stress recorded daily over a period of 30 days was related to 
increases in stimulated IL-6 (Zautra et al., 2008; Davis et al., 2008).  Over time, prolonged 
increases in disease activity can contribute to disease progression. Thus, management of stress is 
of utmost importance for patients with RA.  For individuals with RA, daily stresses go beyond the 
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usual psychological distress.  They have the potential to disrupt physiological processes and 
impact physical functioning. 
 To manage stress and pain, the standard behavioral treatment for RA is pain 
management.  RA is an autoimmune disease of unknown etiology that can severely limit physical 
functioning, increase disability, and cause severe pain (National Institutes of Health, 2009).  There 
is no cure—behavioral treatments are implemented with the aim to instruct RA patients in specific 
strategies to cope with pain as it arises.  Cognitive behavioral therapy (CBT) is the standard 
behavioral treatment and randomized clinical trials comparing psychosocial therapies have shown 
CBT to be especially effective in improving pain coping, while also reducing pain, and mitigating 
depressive symptoms to a lesser degree (Astin, Beckner, Soeken, Hochberg, & Berman, 2002).  
Reduction of pain is a worthwhile and valued endeavor; however, these pain management 
interventions sometimes neglect to directly target the psychological distress that results from and 
contributes to chronic pain. 
 For RA patients, pain is a part of life and the chronicity of this syndrome provides ample 
opportunity for management of stress-related pain.  Pain management is obviously a priority in 
management of this chronic disease; however, interventions that encourage better emotion 
regulation by increasing the ability to regulate negative affect (NA) and the ability to view one’s 
happiness independent of external and potentially discouraging circumstances can have the added 
benefit of improving psychological well-being.  Adopting this mindset may be better in the long 
run because over time, it promotes better strategies to deal with stress, instead of coping with pain 
as it arises. 
Mindfulness-based interventions are aimed at these goals.  Definitions of mindfulness 
vary, but generally include an attentional component and an attitudinal, acceptance-based 
component (Bishop, 2004).  Mindfulness has been found to predict less negative psychological 
distress and increased psychological flourishing, here relayed as two related but independent 
processes (Reich, Zautra, & Davis, 2003).  Some of the proposed mechanisms that explain the 
relationship between mindfulness and mental health are: clarity about one’s internal experience, 
3 
the ability to regulate NA, and the ability to view one’s happiness independent of external 
circumstances, rumination (Coffey, Hartman, & Fredrickson, 2010). 
 Zautra and colleagues (2008) tested a mindfulness-based intervention (M) targeting 
affective disturbance in RA patients.  Mindfulness-based programs have been implemented in 
various clinical populations with much success (Baer, 2003).  Teasdale and colleagues (2000) 
implemented mindfulness-based cognitive therapy (MBCT) to prevent recurrence of major 
depression by reducing metacognitive awareness and changing the individual’s relationship to 
negative thoughts versus changing thought content (Teasdale et al., 2002).  The intent to change 
experience, rather than behaviors, is consistent in mindfulness-based stress reduction (MBSR) for 
individuals with chronic pain (Kabat-Zinn, 1982; McCracken, Gauntless-Gilbert, & Vowles, 
2007).  Beyond blunting the negative impact of chronic pain in reducing perceptions of bodily 
pain, improving physical functioning, decreasing occurrence of psychiatric symptoms, and 
lessening perceived stress (e.g., Rosenzweitg et al., 2010; Shapiro, Oman, Thoresen, Plante, & 
Flinders, 2008; Carmody & Baer, 2008), mindfulness-based interventions also promote well-being 
(Brown, Ryan, & Cresswell, 2007).  In a cohort study examining the effects of MBSR in chronic 
pain patients, individuals with arthritis reported pre to post changes in increased perceptions of 
health (d = .82) and increased vitality (d = .88) (Rosenzweig et al., 2010). 
The current investigation is based on Zautra and colleagues’ research on emotion 
regulation and adaptation to chronic pain (e.g. Zautra, Smith, Affleck, & Tennen, 2001; Zautra et 
al., 1995; Zautra, Affleck, Tennen, Reich, & Davis, 2005).  Research from this lab and others 
suggests positive interpersonal events promote resilient functioning and positive well-being 
(Zautra et al., 2008).  Utilizing a resilience-based approach, the M intervention’s intent was 
twofold: to reduce the negative impact of stressful life events, and to enhance the ability to sustain 
positive social engagements in spite of pain and stress. 
In a sense, both M and P interventions target the stress response.  The P intervention 
solely aims to manage pain and in doing so it may reduce stress associated with a pain episode, or 
perhaps alleviate existing stress exacerbated by pain.  While P intervention strategies are 
reactionary to the stressor and may aid in recovery from stress related to pain, the M intervention’s 
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focus on more effective emotion regulation may actually dampen the initial stress response.  
Mindfulness training promotes non-reactive awareness to negative emotions and thoughts, 
resulting in a “distancing” from these potentially reactive states (Chambers, Lo, & Alle, 2008).  
This mechanism may explain why RA patients in the M group have lower average levels of NA 
and higher levels of PA.  These individuals may continue to feel the same levels of pain, but they 
experience less distress about the pain.  It can be extrapolated that RA patients in the M condition 
were less reactive to stress.  The use of self-report diary data is useful in describing the interplay 
between stress and affect.  However to more definitively examine differences in stress response, 
examination of stress responses within a laboratory stress induction paradigm is needed. 
The current study extended Zautra and colleagues’ (2008) mindfulness intervention 
research by examining responses to induced stress within a controlled, laboratory setting.  To the 
author’s knowledge, no studies have utilized stress induction to examine treatment effects in a 
mindfulness-based intervention.  Careful examination of the stress response is particularly 
important in research in RA, a disease characterized by stress reactivity.  Because the M condition 
focused on emotion regulation, measures of affective reactivity and recovery from induced 
stressors allowed for the evaluation of the intervention’s proposed mechanism of change.  
Emotional reactions to stress have the ability to perpetuate and worsen the effects of a stressor 
(Chida & Hamer, 2008).  Targeting affective responses to stress may mitigate the negative effects 
of stress on an individual and promote emotional well-being over and above that which may occur 
through cognitive pain management alone.  Thus, this study of affective reactivity furthers our 
understanding of how individuals emotionally respond to stress, and whether an emotion 
regulation intervention (M) can directly affect and potentially change the stress response. 
As we consider the role of affective response to stress, we must also consider the role of 
underlying affective disturbance.  Several studies report an association between arthritis and 
psychiatric disorders—depression in particular.  In a review of 12 independent studies comparing 
depression in RA patients and depression in healthy controls, rates of depression were higher in 
RA patients than in the controls (Dickens, McGowan, Clark-Carter, & Creed, 2002).  The 
direction of the relationship between depression and arthritis was further clarified in Land and 
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colleagues’ (2010) population-based longitudinal study in which arthritis diagnosis predicted later 
depression.  In response to Land and colleagues, Nicassio (2010) added that while pre-existing 
depression did not predict the onset of arthritis, secondary depression contributed to adverse health 
outcomes such as interference of functioning, reduction of medical adherence, and use of 
maladaptive health behaviors.  Additionally, depression exacerbates the inflammation process, and 
this has been supported in studies showing increased levels of proinflammatory cytokines in 
depressed individuals with RA, compared to non-depressed patients (Zautra, Hamilton, Potter, & 
Smith, 1999; Zautra et al., 2004). 
The parent study from which this current investigation is based has already yielded 
valuable information about the relationship between stress and recurrent depression in RA 
patients.  During stress induction, RA patients with a history of two or more episodes of major 
depression reported more pain at baseline, and higher pain in response to stress induction 
compared to RA patients with one episode or no history of depression (Zautra et al., 2007).  
Interestingly, the two groups did not differ in average pain and other daily diary measures, but 
patients with a history of depression had significantly stronger associations between pain and 
various aspects of daily emotional experience than did the never-depressed patients (Zautra et al., 
2006).  The previously depressed also engaged in pain coping by venting emotions, reported 
higher negative mood, and lower positive mood—even after controlling for current depressive 
symptoms (Zautra et al., 2008).  These findings indicated that recurrent depression was associated 
with greater pain and pain reactivity, and more mood disturbance, suggesting the presence of 
emotion dysregulation. 
RA patients with a history of recurrent depression represent a subset of RA patients 
particularly sensitive to emotional turmoil related to pain and stress.  Patients in the M 
intervention with a history of recurrent depression benefited the most in affective functioning.  
These RA patients reported significant changes from pre-intervention to post-intervention in 
decreases in NA and increases in positive affect (PA) relative to patients in the P and education 
only control groups (Zautra et al., 2008).  This finding suggests better daily emotion regulation in 
the M group, especially for RA patients with a history of recurrent depression.  In effect, these 
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patients were better able to capitalize upon the emotion regulation skills learned in the M group 
relative to the other groups.  It was expected that these group differences would be reflected 
similarly under conditions of laboratory-controlled stress induction. 
The current investigation primarily examined group differences in affective response to 
lab-induced stressors.  The outcomes of interest were negative affect (NA) and positive affect 
(PA). The main study hypotheses were as followed: 
1. All groups (M, P, E) would demonstrate quadratic functions across the lab 
induction procedure. 
a. For all groups, NA would demonstrate a negative quadratic function, with 
NA increasing and peaking during implementation of the stressors, then 
decreasing back to baseline levels of NA once stress induction is complete. 
b. All groups (M, P, E) would demonstrate a positive quadratic function of PA 
across the lab procedure, with PA decreasing during stressors, and 
increasing back to baseline levels of PA once stress induction was 
complete. 
2. All groups would exhibit similar changes in NA and PA after initial 
presentation of the stressor—there would be no group differences in initial 
reactions to stressor.  The M group would exhibit quicker affective recovery 
relative to P and E groups, and this would be evident in  
a. Lower NA, after initial stressor (a more negative linear function) 
b. Higher PA after initial stressor (a more positive linear function) 
Secondly, the potential effects of a history of recurrent depression (RD+) were explored to 
evaluate whether this subset of individuals differed from RA patients without a history of 
recurrent depression (RD-) 
3. It was predicted that M/RD+ would demonstrate faster recovery than all other 
groups, as evidenced by the greatest: 
a. Decreases in NA after initial stressor was presented, and 
b. Increases in PA after initial stressor was presented. 
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Lastly, potential testing effects of the Solomon-6 design utilized in the study were explored.  
Approximately half of the participants underwent a pre-intervention laboratory session. 
4. It was predicted that testing effects were likely to be evident, with 
participants who underwent a pre-intervention lab being less reactive to the 
stressors at post-intervention lab stress induction.  The same affective 
patterns would emerge, but to a lesser degree. 
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Chapter 2 
METHOD 
Overview of the Study 
Once screened into the study and consented, participants completed initial questionnaires 
about demographic information.  Participants were then clinically evaluated for a history of major 
depression.  A second set of questionnaires assessing for pain and depressive symptoms was then 
completed.  Prior to the intervention, participants completed 30 days of daily diaries assessing 
joint pain, negative and positive affect, and depressive symptoms.  Upon completion of the daily 
diaries, half of participants were randomly selected to undergo a pre-intervention laboratory pain 
assessment with stress induction.  Blood draws were collected at different time points over the 
course of the lab.  Twenty to 28 participants were grouped into one of the eight intervention 
waves.  Participants were randomly assigned to one of three treatment conditions using a random 
numbers table.  At post-intervention, all participants underwent diary assessment and laboratory 
assessment. 
Participants 
A total of 144 participants (68.1% women, 31.9% men) were randomized to receive 1 of 
3 study interventions.  Of the 144 participants, 16 either dropped from the study, did not complete 
the intervention, or were lost to follow-up.  The remaining 128 participants completed a post-
intervention laboratory assessment and were included in the analyses.  Participants were recruited 
from the Phoenix, AZ metropolitan area through solicitations at health fairs, to Arthritis 
Foundation members, local physician offices, and from rheumatologist referrals at the Carl T. 
Hayden Veterans Affair (VA) Medical Center.  Written confirmation of RA diagnosed from 
rheumatologists was required.  RA patients taking cyclical estrogen replacement therapies or with 
a history of lupus were excluded from the study.  The average duration of RA disease was 11.5 
years for female participants and 16.1 years for male participants.  The mean age was 51.2 years 
for women and 61.9 years for men.  Eighty-five percent of the women and 83% for the men 
identified as Caucasian.  Average annual family income for men was in the $25,000 to $29,000 
range and $30,000 to $39,000 range for women. 
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Intervention Plan 
The study compared a mindfulness-based emotion regulation program (M) with a 
cognitive behavioral pain management (P) program.  The interventions were compared to an 
education control group (E). 
All intervention conditions followed an analogous format.  Each 8-week treatment was 
comprised of weekly 2-hour modules with specific themes relating to the content of the 
intervention.  The initial session included an intervention overview and rationale for use.  
Subsequent sessions addressed specific objectives to build on skills relevant to the intervention.  
Treatment sessions were facilitated by a doctoral level psychologist and an advanced doctoral 
student trained in CBT methods and behavioral medicine.  Therapists introduced educational 
information, implemented skill-based exercises, and reviewed participant understanding and 
application of skills learned.  Therapists also assigned weekly homework related to session 
activities, followed by a review of homework at the beginning of the following session to 
reinforce learning.  Interventions were carried out in groups of 5 to 8 participants (average group 
size = 6). 
Pain management (P).  The P intervention utilized standard cognitive behavioral 
techniques to increase pain management skills.  Modules included: (a) introduction of pain 
concepts; (b) relaxation training; (c) autogenic training and other relaxation techniques; (d) 
activity pacing and daily activities management; (e) cognitive coping; (f) alternative pain 
management approaches; memory and concentration; (g) managing intense pain episodes; 
problem-solving; and (h) relapse prevention, generalization, and maintenance. 
Mindfulness-based emotion regulation (M).  Unique to other mindfulness-based 
therapies, this program emphasized skills training in order to sustain positive emotional 
experience, especially with regard to interpersonal relationships.  The M intervention utilized 
mindfulness meditation components common to other mindfulness-based interventions like MBSR 
(Kabat-Zinn, 1982) and MBCT (Teasdale et al., 2000), though relatively shortened in duration in 
order to ensure an equivalent experience across group conditions. 
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The program modules included: (a) mindfulness and the bidimensional model of 
emotion; (b) mindfulness and awareness; (c) emotional clarity and well-being; (d) acceptance, 
negative thoughts, and reframing; (e) positive emotions and pleasant event scheduling; (f) 
enhancing social relations; (g) intimacy, stress, and mindfulness; and (h) maintenance and 
generalization. 
Education-only (E).  The E condition served as a comparison group to the M and P 
interventions by controlling for nonspecific therapeutic effects.  This condition consisted of a 
series of instructional presentations about the RA condition and related topics in health.  Modules 
in the E condition included: (a) introduction to RA: definitions, pathophysiology, and 
epidemiology; (b) prognosis and treatment, diagnostic tests, medical specialists; (c) RA 
medications, medication use; (d) neurophysiology of pain (surgical intervention); (e) natural 
remedies (nutrition, diet); (f) exercise and sleep; (g) communication with your doctor and traveling 
with RA; and (h) review and group closure. 
The utmost effort was put forth in ensuring the objectives for each condition were 
addressed only in the corresponding intervention.  For instance, stress and pain management were 
only discussed in relation to sustaining positive well-being within the M intervention.  Discussions 
about emotions and well-being were not addressed in the P group—which solely focused on how 
to manage pain.  Coping strategies and emotion were purposefully omitted in the E group. 
Procedure 
 At the outset of the lab assessment participants were given detailed instructions about the 
lab procedure, in addition to a second informed consent.  An initial 10-minute rest period was used 
to establish baseline measures prior to periods of stress induction—a standard speech task (Davis, 
1999; Davis, Twamley, Hamilton, & Swan, 1999) and a discussion about a recent interpersonal 
conflict designed to induce stress (Davis, Zautra, & Reich, 2001).  A 20-minute recovery period 
following the stress inductions followed.  Self-report measures of PA and NA were taken at 
baseline, after each stress induction, and after recovery for a total of 4 assessments.  
 Baseline period.  The participant was asked to sit quietly and rest while relaxing music 
was played.  A research assistant suggested to the participant to take a mental vacation to a 
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favorite place where s/he felt safe and comfortable, while relaxing his or her body and mind.  
After 10 minutes, a blood sample was collected and self-report questionnaires administered. 
First stress induction.  Then the participant was informed that s/he would take the next 
10 minutes to prepare a 5-minute speech describing his/her best and worst characteristics.  The 
participant was told that two research assistants would be present to evaluate the speech for 
content, clarity, and style; and that the speech would be taped so that a team of psychologists 
could evaluate the speech at a later time.  If the participant stopped before the 5 minutes were 
over, s/he was asked to continue.  If the participant was unable to continue, the research assistants 
remained in the room without speaking until the 5 minutes had passed.  Once the speech task was 
complete, the second blood sample and second set of questionnaires was collected. 
 Second stress induction.  For the second stress induction the participant was asked to 
think about a recent conflict with an important person in his/her life that was stressful and elicited 
strong feelings at the time.  First, the research assistant asked the participant to visualize the event 
in great detail (i.e. where the conflict took place, what things they could see, hear, and smell).  
Then the participant was told to attend to the person involved in the conflict—how they entered, 
what s/he looked like, what was done or said.  The research assistant then directed the participant 
to reflect on his/her own thoughts and physiological reactions (change in heart rate, tension in 
muscles).  Finally, the participant was asked to describe the event to the research assistant paying 
special attention to emotions and feelings experienced, cognitions, how s/he coped, whether s/he 
talked about the event to someone else, and what s/he would have done differently.  The stress 
interview continued for 15 minutes, followed by a third blood sample and set of questionnaires. 
 Recovery period.  Lastly, the participant was asked to relax in the same manner as the 
baseline period.  After 20 minutes, the fourth and final blood sample and set of questionnaires was 
collected.  The participant was then debriefed and given $90 for participation. 
Measures 
Structured clinical interview for DSM IV (SCID-I).  The SCID-I was used to assess 
for history of major depression.  Interviews were conducted by advanced clinical psychology 
students or postdoctoral students trained to administer and code the SCID-I, under the supervision 
12 
of a licensed clinical psychologist.  Interviews were conducted by telephone and were audiotaped 
with the participants’ consent (see Zautra et al., 2007 for a detailed description of the depression 
assessment procedure).  Telephone interviews are equivalent to face-to-face interviews in 
assessing Axis I depressive disorders (Rohde, Lewinsohn & Seeley, 1997; Simon, Revicki, & 
VonKorff, 1993).  Major depressive episodes could not be due to uncomplicated bereavement, 
injury or illness, alcohol or drugs, or medication use.  Recurrent history of depression (RD) is 
defined as two or more episodes of major depression. 
Positive and negative affect.  PA and NA were measured using the Positive and 
Negative Affect Schedule (Watson, Clark, & Tellegen, 1988).  Participants were given a list of 10 
positive mood adjectives (current sample alpha reliability = .906) and 9 negative mood adjectives 
(alpha = .879).  The NA subscale of the PANAS is comprised of 10 negative mood adjectives, 
however 1 negative mood adjective was left out in error, thus a modified 9-item measure of NA 
was assessed instead.   Participants were asked to rate the extent to which they felt these mood 
adjectives at that point in time using a 5-point scale from 1 (“very slightly or not at all”) to 5 
(“extremely”). PA and NA were assessed at four time points during the experimental session. 
Analytic Strategy 
 This study employed several sets of analyses utilizing multilevel random effects 
modeling.  The data were coded by Lab Interval, a repeated, within person factor with four levels 
that corresponded with the four lab intervals during the stress induction procedure: baseline, 
stressor 1, stressor 2, and recovery.  Linear and quadratic effects of Lab Interval were expected 
and modeled accordingly.  The interactions of Lab Interval by Treatment Group were indicative of 
differential effects of the interventions over the duration of the laboratory stress induction session.  
The first set of analyses looked at differences in affective outcome for all participants who 
completed a post-intervention laboratory session.  In light of the correlation between PA and NA, 
a subset of these analyses included PA as a covariate when testing for differences in NA, and 
conversely NA as a covariate for analyses with PA as the outcome.  The second set of analyses 
explored the effects of a history of recurrent depression on study outcomes.  The third and final set 
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of analyses explored testing effects on PA and NA resulting from the Solomon 6 design of the 
study. 
The outcomes investigated were post-intervention PA and NA.  The independent 
variables included in the models were: assigned Treatment Group and Lab Interval.  Treatment 
Group was treated as a categorical between person factor with three levels: education control, pain 
management, and mindfulness/emotion regulation. Lab interval was a repeated, within person 
factor with four levels that correspond with the four lab intervals during the stress induction 
procedure: baseline, stressor 1, stressor 2, and recovery.  For each lab assessment, self-reports of 
NA and PA were collected at each of the four lab intervals.  Categorical predictor variable 
Pre/Post delineated between participants who received both pre- and post-intervention lab 
assessments and participants who received post-intervention lab assessments only.  Significant 
interactions with Pre/Post indicated the presence of testing effects introduced by the Solomon 6 
study design.  History of Recurrent Depression was treated as a dichotomous variable, where RD- 
represented individuals with a history of 0 or 1 major depressive episode, and RD+ represented 
those with a history of 2 or more major depressive episodes. 
All multilevel analyses were conducted using SAS PROC MIXED (Littell, Milliken, 
Strong, & Wolfinger, 1996).  The MIXED procedure utilized estimation techniques that allowed 
for missing data due to data collection errors and/or planned missing observations, thus all 128 
participants were included in the analyses.  Treatment effects, testing effects, and effects of 
recurrent depression were estimated with dummy coded variables.  For example, the basic 
equation to assess NA would be as follows: 
Negative affect = b0 + b1 Lab Interval (linear) + b2 Lab Interval (quadratic) + b3 Treatment Group 
+ b4 Lab Interval (linear) x Treatment Group + b5 Lab Interval (quadratic) x Treatment Group + 
residual error 
To assess for the effect of recurrent depression, Depression History was included in the basic 
equation above and allowed to interact with the other predictors. To assess testing effects, Pre/Post 
was included in the equation above and allowed to interact with the other predictors. PA was 
modeled in the same manner as NA. 
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An ARH (1) error structure was used to model significant heterogeneity in the 
autocorrelation between adjacent Lab Interval scores within person.  An unstructured covariance 
matrix was selected for models that did not have significant autocorrelation between Lab Interval 
scores. 
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Chapter 3 
RESULTS 
Preliminary Comparisons of Groups 
 Table 1 displays the demographic characteristics of the study sample across the three 
intervention groups.  The treatment groups were comparable in age (F(2,127) = 1.45, p = .24), 
gender (χ2(2, N = 128) = 5.39, p = .07), ethnicity (χ2(8, N = 125) = 8.45, p = .39), and duration of 
time from RA diagnosis to study entry (F(2,123) = 1.34, p = .27).  History of recurrent depression 
did not differ between treatment groups (χ2(2, N = 127) = 3.02, p = .22).  The number of sessions 
attended did not vary across groups (F(2,94) = 2.13, p = .13), indicating comparable “dose” of 
intervention received across treatment groups. 
Group Effects on Negative Affect 
 Two sets of analyses were required to assess for all possible group comparisons.  The 
first analysis contrasted intervention groups P and M against attention control group E.  The 
second analysis was a direct comparison of group P versus group M.  For all comparisons, 
significant linear and quadratic effects (all p values < .0001; see Tables 3 & 4) were present for 
NA across the four intervals during the stress induction procedure. NA increased from baseline to 
stressor 1, NA continued to increase from stressor 1 to stressor 2, and finally NA decreased from 
stressor 2 to relaxation (see Figure 1), supporting Hypothesis 1a. 
Group comparison analyses indicated the M group was significantly different than P and 
E groups (see Tables 3 & 4).  P and E groups did not differ significantly.  Significant Group 
effects showed that the M group reported lower levels of NA overall (MM = 1.33, SDM = .53) than 
the E group (ME = 1.52, SDE = .67, t = 2.01, p = .047) and the P group (MP = 1.54, SDP = .74, t = 
1.78, p = .079; see Table 2 for means and standard deviations).  Significant ‘Group x Interval’ 
linear and quadratic effects (all ps < .05) also demonstrated that M was statistically different than 
P and E groups.  
Separate analyses were conducted for each Group to obtain slope coefficients to allow for 
comparison between groups (see Table 5).  The M group demonstrated a shallower quadratic 
‘Group x Interval’ effect than the E and P groups (ßM = -.23, ßE = -.35, ßP = -.36).  
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Covarying positive affect on NA.  PA was included as a covariate in the model to assess 
for NA independent of PA.  Analyses of NA controlling for PA yielded comparable results to 
analyses in which PA was not included as a covariate (see Tables 6 & 7 for group comparisons 
and Table 8 for beta coefficients).  Three of four fit statistics indicated a worsening of goodness of 
fit with the inclusion of PA as a covariate.  Because covarying PA did not improve goodness of fit, 
the use of PA as a covariate was not included in subsequent analyses of NA. 
History of recurrent depression on NA.  The effects of a history of recurrent depression 
were assessed by including RD as a predictor for NA.  Again, two sets of analyses were conducted 
to assess for all possible group comparisons (see Tables 9 and 10).  Significant group differences 
were only evident between M and P groups (see Figure 2).  Significant ‘RD by Interval (linear & 
quadratic)’ effects (both ps = .022) and a marginal RD effect (p = .082) suggest that not only did 
RD+ individuals generally report higher NA than RD- individuals, but RD+ individuals also 
demonstrated greater increases of NA in response to the stressor tasks.  Furthermore, a significant 
‘RD by Interval by Group’ effect (p = .010) showed that Group modified the relationship between 
RD and Interval such that the M group reported less of an increase in NA in response to stress 
induction than P group.  Figure 2 distinguishes the trajectories of NA by Group and RD status.  
The P group was divided into two subgroups—P/RD- and P/RD+ —and the M group was divided 
into two subgroups—M/RD- and M/RD+.  To summarize, P/RD+ reacted to the stressor tasks 
with the greatest increases in NA, followed by M/RD+, then P/RD-, and lastly M/RD- was the 
least reactive to stress induction. 
Separate analyses were conducted for each group to obtain slope coefficients for each 
group and to aid in the interpretation of group differences between M and P groups (see Table 11).  
There were no significant effects for RD or ‘RD by Interval’ interactions for the P and E groups.  
Within the M group, RD+ individuals reported greater increases in NA than RD- individuals in 
NA at time 2 and time 3 (ps < .05, see Table 11).  This finding suggested that the effects of RD in 
the comparison between M and P groups were largely driven by RD’s effects on NA in the M 
group. 
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All four fit statistics demonstrated no improvement in model goodness-of-fit with the 
inclusion of RD as a predictor compared to a model without RD.  Given that Group effects were 
largely comparable between the models with and without RD, RD was not included in models 
assessing for testing effects. 
Testing effects on NA.  Testing effects were assessed by including Pre/Post as an 
additional predictor for NA.  Pre/Post is a categorical variable that indicates whether the 
participant received a pre-intervention lab assessment.  All group comparisons rendered significant 
effects found in previous analyses nonsignificant with the inclusion of Pre/Post as a predictor (see 
Tables 12 & 13 for group comparisons and Table 14 for beta coefficients).  This finding suggested 
that testing effects may be collinear with the Group and Interval effects found in prior analyses.  
To clarify these findings, analyses on NA were conducted excluding participants who 
received a Pre-intervention lab session.  Consistent with initial analyses omitting Pre/Post as a 
predictor, group comparisons demonstrated significant linear and quadratic Interval effects for all 
group comparisons (ps all < .001, see Table 15 & 16 for group comparisons, Table 17 for beta 
coefficients).  All groups began at comparable levels of NA and NA increased similarly at Interval 
2 (first stressor).  After Interval 2, the groups appeared to diverge at Interval 3 (second stressor), 
with NA continuing to increase for the P group and NA increasing slightly for the E group, 
whereas NA decreased for the M group.  All groups returned to similar levels of NA at Interval 4.  
Significant differences in NA between M and P groups were evident across lab interval (see 
Figure 3).  The P group appeared to show greater NA and the M group appeared to show lessened 
NA at Interval 3 compared to the E group, but these differences were not statistically significant.  
Though it appears that the E group served as a baseline measure of NA over the course of stress 
induction, M and P groups did not differ significantly from the E group.  This pattern of NA 
suggested that while all groups ultimately returned to baseline levels of NA, the M group appeared 
to return to baseline levels of NA more quickly than the other groups. 
Group Effects on Positive Affect 
As with NA, two sets of analyses were required to test all possible group comparisons 
(analysis 1: P vs. E, M vs. E; analysis 2: P vs. M).  Significant positive linear and negative 
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quadratic trends were evidenced for both analyses (all ps < .001; see Table 18, 19; for means & 
standard deviations see Table 2).  Similar to the trajectories of NA across Interval, PA increased 
from baseline to stressor 1 and continued to increase from stressor 1 to stressor 2, then decreased 
from stressor 2 to relaxation.  Figure 3 represents the changes in PA across the 4 Lab Intervals, by 
Group.  The negative quadratic Interval effect is contrary to the hypothesis that PA would decrease 
in response to stress induction (Hypothesis 1b). 
Analyses of contrasts between groups allowed for comparisons of treatment group.  M 
differed significantly from both P and E groups (ps < .05, see Table 18 & 19).  P and E groups did 
not differ in PA.  Significant ‘Group by Interval (both linear & quadratic)’ effects showed that the 
M group displayed slower linear increases in PA across Interval (M<E, t = -2.00, p = .046; M<P, t 
= -2.37, p = .018), and a shallower quadratic Interval effect for PA (M>E, t = 1.88, p = .061; M>P, 
t = 2.56, p = .011).  Separate analyses were conducted for each group to obtain slope coefficients 
for each group so that they could be compared (see Table 5).   
M group reported relatively high levels of PA that were stable across the lab procedure.  
PA decreased from Interval 3 (stressor 2) to Interval 4 (recovery) for each group, however PA 
decreased to a lesser extent in the M group compared to the other groups. 
PA, Covarying negative affect.  NA was included as a covariate in the model to assess 
for PA independent of NA.  As before, analyses were conducted to compare groups.  Significant 
linear and quadratic Interval effects (ps < .01) were found only in the comparison between the M 
and E groups (see Tables 20 & 21 for contrasts and Table 8 for betas).  The results of the analyses 
between M and E were largely identical to analyses of PA omitting NA as a covariate.  Significant 
Group and ‘Group x Interval (quadratic)’ effects were retained (ps < .05), though linear and 
quadratic Interval effects were rendered nonsignificant and the previously significant ‘Group by 
linear Interval’ effect became marginally significant (p = .054). 
All four fit statistics indicated no change in goodness of fit with the inclusion of NA as a 
covariate.  Because covarying NA did not improve goodness of fit, NA was not included in 
subsequent analyses of PA. 
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History of Recurrent Depression on PA.  In order to assess for the effects of history of 
recurrent depression on PA, RD was included in analyses and allowed to interact with all other 
predictors.  Results of the group comparisons were largely comparable to analyses without RD 
(see Tables 22 & 23 for contrasts, Table 11 for betas).  No RD or ‘RD by Interval’ effects were 
significant.  RD did not interact with other predictor terms, suggesting no evidence for effects on 
PA due to history of recurrent depression.   
Testing Effects on PA.  Testing effects were evaluated by including Pre/Post as an 
additional predictor for PA.  The significant group differences between M versus P, and M versus 
E groups were not preserved with the inclusion of Pre/Post as a predictor (see Table 25).  The 
results of these contrasts were largely different than previous analyses with PA as an outcome.  
There was a significant main effect for Pre/Post and significant interactions with Pre/Post (see 
Table 24) suggesting that testing effects were present. 
To clarify these findings, analyses on PA were conducted excluding participants who 
received a Pre-intervention lab session.  Group comparisons demonstrated significant linear and 
quadratic Interval effects for all groups (ps all < .0001, see Tables 26 & 27).  Significant 
differences in PA between M and P groups were evident across lab interval (see Figure 5).  These 
differences were comparable to the results obtained from initial analyses on PA in which the entire 
sample was utilized—including participants who received pre-intervention lab assessment—and 
the Pre/Post variable was omitted.  Additionally, these prior analyses demonstrated group 
differences between M and E groups, but this comparison was not significant in analyses of the 
post-only subset of participants. 
All three groups appeared to have relatively similar levels of PA across interval 1, 2, and 
3 (see Figure 7).  Levels of PA seemed to diverge from Interval 3 to Interval 4.  While the M 
group appeared to sustain consistently high levels of PA across the lab induction procedure with a 
slight dip in PA at Interval 4, the P group showed a drastic drop in PA at Interval 4 (recovery).  
This suggests that while the stressor tasks elicited comparable levels of PA in response to the 
stressors, the groups differed to the extent they retained those levels of PA at the final Interval 
(recovery).  
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Chapter 4 
DISCUSSION 
 The main purpose of this study was to examine the stress-reducing effects of two active 
interventions for RA patients.  Differences consistently emerged between the M group and P 
group, as well as between the M group and E attention control.  Compelling evidence was found 
for changes in affective responding under conditions of laboratory-induced stress for RA patients 
who had underwent a mindfulness emotion regulation intervention, particularly when compared to 
RA patients who participated in the CBT-pain management intervention.  Two affective outcome 
variables were examined—positive affect and negative affect—and significant group differences 
emerged for both.  Overall, the M group consistently differed from the P group in many analyses.  
The significant differences between group M and group P persisted even after partialing out the 
effects of other predictors (e.g. affective covariates, history of recurrent depression).  Testing 
effects were evident in the analyses, but the same pattern of group differences were found after 
excluding patients who underwent a pre-intervention lab visit.  The M group differed from the E 
group for both NA and PA in analyses that included the entire sample, but this comparison was 
nonsignificant in analyses that excluded participants who received a pre-intervention laboratory 
assessment. 
 As predicted, the M group differed significantly from the P and E groups in negative 
affect, though not in the way anticipated.  The way in which the groups differed was not 
characterized by the swiftness of recovery from stressors as was predicted in Hypothesis 2, but 
from differences in reactivity to stress.  The trajectories of NA in the M group were characterized 
as consistent and non-reactive during the stress induction procedure, whereas the P group 
demonstrated more reactive affective responses to stress, suggesting a dampening of NA reactivity 
for the M group relative to the other groups.  Because half of the sample received a pre-
intervention laboratory session as a part of the Solomon-6 study design, testing effects were 
considered as a potential influence on reactivity to stress.  Analysis of the post-only subset of 
participants confirmed that the M group exhibited less NA reactivity to stress than the P group, but 
not the E group.  Furthermore, the M group appeared to recover more quickly from the initial 
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stressor than the P group, demonstrating decreases in NA and continued recovery even as the 
group underwent the second stress induction procedure.  These results were consistent with 
Hypothesis 2a. 
 The group differences in PA were largely similar to those for NA.  However, the 
trajectory of PA was in the opposite direction that was predicted.  PA was elicited during the 
stressor tasks.  It was predicted that PA would decrease in response to stress (Hypothesis 1b), but 
the opposite occurred—PA increased immediately following the stressor tasks.  These findings 
indicated that the stressor tasks elicited increases in PA, suggesting all participants—regardless of 
group—recruited PA in response to stress.  This somewhat counterintuitive reaction to negative 
stimuli may represent an emotional immune response (Wilson & Gilbert, 2005).  Other researchers 
have posited that when faced with stimuli that induce negative emotional states, an individual will 
begin to cope immediately (DeWall & Baumeister, 2007).  For example, DeWall and Baumeister 
(2007) found that reminders of mortality increased the accessibility of positive emotional 
information.  The current study’s findings that PA immediately increased after stress induction 
provide further evidence that the coping process is immediate and automatic.  Increases in PA in 
response to stress were common to all groups, but the magnitude of these increases differed by 
intervention group.  As with NA, the M group appeared to demonstrate less reactivity to the 
stressors compared to the P and E groups.  This lack of PA reactivity taken together with 
dampened NA reactivity suggests that because the stressors did not induce negative emotions to 
the same degree as the other groups, the M group had less of a need to cope with the stressors and 
therefore did not demonstrate the same degree of increases in PA as the other groups.  All groups 
showed similar levels of PA during the stressor tasks, but PA decreased to a lesser degree at 
recovery for the M group than the P and E groups.  The M group’s response to stress seemed to be 
characterized by lessened loss of PA (and less reactivity to stress) and sustained levels of PA 
across the lab interval.  This finding is compatible with the hypothesis that the M group would fare 
better than the other groups (Hypothesis 2b), though it appeared that the M group demonstrated 
consistent sustainability of PA, rather than affective recovery from stress induction. 
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Compared to the other groups, the M group appeared to more capably manage negative 
affect and to retain positive emotions independent of the negative and potentially distressing stress 
induction procedure.  The stress-reducing effects of mindfulness practice have been well 
documented (e.g., Baer, 2003) and the M group’s dampened affective response to stress is 
consistent with recent research that shows mindfulness facilitates stress processing via lower 
emotional reactivity to stressors and quicker recovery from unpleasant emotional states 
(Weinstein, Brown, & Ryan, 2009).  Several mechanisms have been proposed to explain the 
stress-reducing effects of mindfulness.  Research with nonclinical samples suggests that the ability 
to manage negative emotions and non-attachment (e.g., extent that happiness and positive 
emotions are independent of specific outcomes and events) mediate the relationship between 
mindfulness and mental health (Coffey et al., 2010).  Improved attention and greater 
parasympathetic activity have been associated with mindfulness in a randomized control trial 
comparing a brief 5-day mind-body integrative intervention to a relaxation control (Tang et al., 
2007; Tang et al., 2009).  Clarity of one’s affective experience is another mechanism.  Individuals 
high in trait mindfulness demonstrated greater widespread prefrontal cortical activation and 
reduced bilateral amygdala activation during affect labeling (Cresswell, Way, Eisenberger, & 
Lieberman, 2007).  Garland, Gaylord, and Fredrickson (2011) propose that cognitive variables, 
such as positive reappraisal, mediate the relationship between dispositional mindfulness and 
reduction of stress.  These are potential mediators that may help to explain the connection between 
mindfulness and psychological flourishing. 
It is interesting that most of the differences were found between the two active 
interventions, rather than between the active interventions and attention control.  There were no 
significant differences between the P and E group, suggesting that the P intervention did not 
contribute to any changes in affect.  Indeed, the P group consistently seemed to fare worse than 
both groups, evidencing the greatest affective reactivity to stress—even more reactive the E 
group—and greatest loss of PA at recovery.  Though the differences between the P and E groups 
were not significant, this “null result” prompts further questions about the nature of this finding.  
Two potential explanations emerge: first, it is possible that utilizing a cognitive approach called 
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even more attention to the negative aspects of experience without directly changing those aspects, 
thus increasing unpleasant feelings to a greater extent than if no action was taken at all.  Cognitive 
strategies emphasized taking an evaluative approach that included closely examining maladaptive 
thoughts and beliefs and actively replacing them with more adaptive alternatives.  This process 
may have been effortful and fatiguing, which could have perpetuated negative feelings even 
further.  Perhaps cognitive strategies simply took longer to work and recovery occurred later than 
it would naturally without intervention.  An alternative explanation is that cognitive strategies did 
not alter affect at all, and that pre-to-post intervention decreases in self-report pain, depressive 
symptoms, and pain control in this group (Zautra et al., 2008) were largely due to changes in 
cognition.  
The findings from the present study underscore the differences between mindfulness-
based and CBT-based interventions and highlight the potential value of incorporating elements of 
mindfulness into the gold standard CBT interventions.  CBT has been shown to increase positive 
cognitive coping (e.g., active coping) and appraisal and reduce behavioral expressions of pain 
(Morley, Eccleston, & Williams, 1999), but in utilizing CBT without paying attention to emotion 
regulation, we may be introducing awareness of negative psychological states and affect without 
giving individuals the tools with which to deal with them.  The addition of mindfulness techniques 
may supplement the benefits of cognitive behavioral therapies. 
Positive affect may serve as a source of resilient responding.  In a sample of women with 
osteoarthritis or fibromyalgia or both, patients with greater positive affect demonstrated lower 
negative affect during times of increased pain and stress (Zautra, Johnson, &Davis, 2005).  
Positive emotion has been studied as a potential source of resilience that works by undoing some 
of the deleterious physiological effects of negative emotion and by promoting faster recovery to 
baseline levels of affect (Fredrickson & Levenson, 1998).  Beyond returning to homeostasis, 
positive affect has been shown to counteract and reverse the negative effects of what Tice and 
colleagues (2007) term “ego-depletion.”  They posit that self-regulation is integral for functioning, 
but requires the use of psychological resources.  Depletion of these stores is counteracted by 
positive emotion, which replenishes and expands the capacity to self-regulate.  Utilizing positive 
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affect may be a natural coping response that those who are well-regulated (e.g., individuals well 
versed in mindfulness practice) are especially able to capitalize on.  Emphasizing the cultivation of 
positive emotion, whether it be by attending to and savoring the positive aspects of experience 
from the mindfulness perspective, or by engaging in pleasant events scheduling as prescribed by 
the cognitive behavioral tradition, is integral for the promotion of emotion regulation. 
 Attention needs to be paid to the effects of depression history, as individuals with a 
history of depression by definition showed deficits in emotion regulation.  Hypothesis 3 examined 
the effects of a history of recurrent depression.  Interestingly, RD only affected the trajectory of 
NA, not PA.  This lends credence to the assertion that NA and PA are independent, albeit related 
constructs (Reich et al., 2003).  Furthermore, history of recurrent depression only affected 
participants in the M group.  Participants in the M group without a history of recurrent depression 
were less reactive to the stressor tasks than those with a history of depression.  This supports the 
preposition that depression history may serve as a risk factor in terms of susceptibility to stress.  
This finding, coupled with the previous finding that M/RD+ group demonstrated pre to post 
changes in increases in PA, reductions in NA, greater coping efficacy, and lessened 
catastrophizing in diary data, suggests that the emotion regulation benefits of mindfulness-based 
techniques (Zautra et al., 2008) may be especially helpful for RD+ individuals, by expanding their 
repertoire of emotion regulation strategies.  Positive emotions have been found to mediate the 
relationship between dispositional mindfulness and depressive symptoms in nonclinical 
individuals (Jimenez, Niles, & Park, 2010). 
There are several limitations in this study.  One challenge faced was disentangling testing 
effects that were a result of the Solomon-6 study design.  This study would have been 
strengthened by including pre-intervention laboratory stress induction data, so that pre-post effects 
could be examined.  However, the presence of testing effects may very well diminish pre-post 
effects.  There is some evidence to suggest that the testing effects found in this study were 
collinear with group effects; however, more work to clarify this assertion is needed.  Another 
limitation of the current study is that recovery from stress was difficult to assess in the M group, 
because they were not as emotionally reactive as the other groups.  Although this result was 
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valuable in and of itself, the muted reaction to stress induction made it difficult to examine 
recovery processes.  Induction of positive, negative, and neutral emotional states may be useful in 
future research.  Also, given that RA patients have chronic pain, examination of pain induction 
procedures and their effects on stress and affect would be especially relevant.  While controlled 
laboratory paradigms offer strengths in standardization, they are often criticized for their lack of 
ecological validity, which is why a multi-pronged approach in which data is collected in multiple 
forms (e.g., diary data) and time frames is valuable.  The findings from the current, laboratory-
based study taken together with the results of the daily diary analyses from the parent study (see 
Zautra et al., 2008) offer a nuanced and complete picture of how mindfulness and cognitive-
behavioral approaches affect emotion regulation in RA patients. 
Many advances have been made in research on mindfulness, yet many unanswered 
questions remain about the mechanisms involved in the processes underlying mindfulness.  This 
study adds to understanding of how mindfulness promotes resilient functioning in chronic pain 
patients.  We have already seen that RA patients who underwent the mindfulness in the study 
reported pre to post intervention changes in a variety of outcomes.  The current investigation 
further clarified the regulatory functions of mindfulness, while simultaneously inviting further 
inquiry about processes of recovery and sustainability of affect. 
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Table 1 
 
Demographic Characteristics By Group 
 
Characteristic 
Group 
M (n = 39) P (n = 48) E (n = 41) 
Gender, n    
     Male 17 15 8 
     Female 22 33 33 
Ethnicity, n    
     White 34 41 33 
     Other 4 7 6 
Age in years, M (SD) 57.13 (15.16) 54.65 (12.68) 52.02 (12.43) 
Years with RA 
diagnosis, M (SD) 
11.34 (11.07) 15.43 (13.91) 11.55 (13.87) 
Median family income $40,000 - $49,999 $40,000 - $49,999 $50,000 - $59,999 
History of recurrent 
depression, n 
   
     0 or 1 depressive 
episode 
31 32 27 
     2 or more depressive 
episodes 
7 16 14 
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Table 2 
 
Means (Standard Deviations) for NA and PA Across Lab Interval by Group 
 
Outcome measure 
Group 
M P E 
Negative affect    
     Lab interval 1 1.15 (.31) 1.20 (.52) 1.15 (.30) 
     Lab interval 2 1.49 (.65) 1.74 (.69) 1.83 (.72) 
     Lab interval 3 1.63 (.63) 2.06 (.88) 1.92 (.77) 
     Lab interval 4 1.07 (.16) 1.16 (.35) 1.20 (.37) 
Positive affect    
     Lab interval 1 2.82 (.73) 2.45 (.88) 2.49 (.88) 
     Lab interval 2 2.97 (.70) 2.91 (.87) 2.80 (.75) 
     Lab interval 3 3.10 (.76) 2.89 (.83) 3.11 (.78) 
     Lab interval 4 2.58 (.87) 2.13 (.92) 2.36 (.93) 
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Table 3 
 
Group and interval effects in the prediction of NA, P vs. E & M vs. E contrasts 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .07 .01 5.33 <.001*** 
Var (1)  .09 .02 6.28 <.001*** 
Var (2)  .43 .06 7.41 <.001*** 
Var (3)  .53 .07 7.74 <.001*** 
Var (4)  .03 .01 2.81 .003** 
ARH (1)  .20 .07 2.81 .005** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  -.25 .19 -1.34 .18 
Between subject (df = 125) 
Group P vs. E .08 .26 0.31 .76 
 M vs. E .55 .27 2.01 .047* 
Within subject (df = 376) 
Interval  1.75 .21 8.37 <.001** 
Interval*Interval  -.35 .04 -8.41 <.001** 
Within & between subject interaction (df = 376) 
Group*Interval P vs. E -.03 .28 -0.09 .93 
 M vs. E -.67 .30 -2.24 .03* 
Group*Interval*Interval P vs. E -.002 .06 -0.03 .98 
 M vs. E .13 .06 2.12 .03* 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 4 
 
Group and interval effects in the prediction of NA, P vs. M contrast 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .10 .03 4.01 <.001*** 
Residual  .24 .02 11.31 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  .23 .22 1.03 .30 
Between subject (df = 85) 
Group P vs. M -.53 .30 -1.78 .08† 
Within subject (df = 253) 
Interval  1.12 .20 5.64 <.001*** 
Interval*Interval  -.23 .04 -5.77 <.001*** 
Within & between subject interaction (df = 253) 
Group*Interval P vs. M .69 .27 2.59 .01* 
Group*Interval*Interval P vs. M -.13 .05 -2.53 .01* 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 5 
 
Beta Coefficients (Standard Error) for Linear & Quadratic Interval Effects on NA and PA by Group 
 
Fixed effects 
Ma Pb Ec 
ß (SE) t ß (SE) t ß (SE) t 
Negative affect       
   Interval 1.11 (.19) 5.88 1.81 (.20) 9.11 1.77 (.19) 9.45 
   Interval*Interval -.23 (.04) -6.03 -.36 (.04) -9.16 -.35 (.04) -9.46 
Positive affect       
   Interval .76 (.18) 4.27 1.42 (.20) 7.25 1.37 (.23) 6.03 
   Interval*Interval -.17 (.04) -4.66 -.30 (.04) -7.88 -.28 (.04) -6.18 
Note: a dfM = 114. b dfP = 142. c dfE = 120. All p-values < .001
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Table 6 
 
Group and interval effects in the prediction of NA covarying PA, P vs. E & M vs. E contrasts 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .07 .01 5.22 <.001*** 
Var (1)  .10 .02 6.26 <.001*** 
Var (2)  .44 .06 7.29 <.001*** 
Var (3)  .51 .07 7.64 <.001*** 
Var (4)  .03 .01 2.84 .002** 
ARH (1)  .21 .07 2.95 .003** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  -.39 .42 -0.93 .35 
Between subject (df = 125) 
Group P vs. E .07 .26 0.28 .78 
 M vs. E .48 .27 1.78 .08† 
Within subject (df = 373) 
PA  .07 .13 0.55 .58 
Interval  1.77 .47 3.77 <.001*** 
Interval*Interval  -.35 .09 -3.78 <.001*** 
Within & between subject interaction (df = 373) 
PA x Interval -.03 .15 -0.22 .83 
PA*Interval*Interval .007 .03 0.24 .81 
Group*Interval P vs. E -.01 .28 -0.05 .96 
 M vs. E -.62 .30 -2.06 .04* 
Group*Interval*Interval P vs. E -.003 .06 -0.06 .95 
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 M vs. E .12 .06 1.95 .05† 
†p<.10  *p<.05  **p<.01  ***p<.001
 37 
Table 7 
 
Group and interval effects in the prediction of NA covarying PA, P vs. M contrast 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .10 .03 4.02 <.001*** 
Residual  .24 .02 11.25 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  .34 .48 0.59 .56 
Between subject (df = 85) 
Group P vs. M -.49 .31 -1.61 .11 
Within subject (df = 253) 
PA  -.02 .19 -0.08 .93 
Interval  .88 .53 1.65 .10 
Interval*Interval  -.19 .10 -1.85 .07† 
Within & between subject interaction (df = 253) 
PA*Interval .06 .17 0.35 .73 
PA*Interval*Interval -.006 .03 -0.19 .84 
Group*Interval P vs. M .66 .27 2.42 .02* 
Group*Interval*Interval P vs. M -.12 .05 -2.30 .02* 
†p<.10  *p<.05  **p<.01  ***p<.001 
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Table 8 
 
 Beta Coefficients (Standard Error) for PA (Covarying NA), and NA (Covarying PA) by Group 
 
Fixed effects 
Ma Pb Ec 
ß (SE) t p ß (SE) t p ß (SE) t p 
Negative affect          
   Interval 1.46 (.70) 2.09 .04* 1.21 (.67) 1.81 .07† 2.44 (.70) 3.47 <.001*** 
   Interval*Interval -.29 (.13) -2.17 .03* -.26 (.13) -1.98 .0496* -.50 (.14) -3.62 <.001*** 
   PA .16 (.26) .62 .54 -.12 (.26) -.45 .65 .20 (.26) .74 .46 
   PA*Interval -.13 (.23) -.54 .59 .16 (.24) .69 .49 -.25 (.25) -1.01 .31 
   PA*Interval*Interval .03 (.05) .57 .57 -.02 (.05) -.51 .61 .06 (.05) 1.16 .25 
Positive affect          
   Interval .88 (.78) 1.13 .26 .79 (.61) 1.29 .20 1.96 (.77) 2.55 .01* 
   Interval*Interval -.25 (.16) -1.54 .13 -.19 (.13) -1.47 .14 -.45 (.15) -3.02 .003** 
   NA .11 (.77) .14 .89 -.18 (.48) -.39 .70 .23 (.73) .32 .75 
   NA*Interval -.29 (.67) -.43 .67 .27 (.43) -.63 .53 -.47 (.58) -.81 .42 
   NA*Interval*Interval .11 (.14) .79 .43 -.05 (.09) -.54 .59 .14 (.11) 1.26 .21 
Note: a dfM = 111, b dfP = 139, c dfE = 117, †p<.10  *p<.05  **p<.01  ***p<.001 
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Table 9 
 
Group, interval, and RD effects in the prediction of NA, P vs. E & M vs. E contrasts 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .06 .01 4.95 <.001*** 
Var (1)  .08 .01 6.08 <.001*** 
Var (2)  .44 .06 7.21 <.001*** 
Var (3)  .50 .07 7.53 <.001*** 
Var (4)  .03 .01 3.48 <.001*** 
ARH (1)  .18 .07 2.56 .01* 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  -.21 .23 -0.90 .37 
Between subject (df = 121) 
RD  -.14 .39 -0.37 .71 
Group P vs. E -.12 .31 -0.37 .71 
 M vs. E .65 .31 2.09 .04* 
Within subject (df = 367) 
Interval  1.62 .26 6.33 <.001*** 
Interval*Interval  -.32 .05 -6.28 <.001*** 
Within & between subject interaction (df = 367) 
RD*Group P vs. E .54 .53 1.01 .32 
 M vs. E -.82 .63 -1.29 .20 
RD*Interval .39 .44 0.90 .37 
RD*Interval*Interval -.09 .09 -1.01 .31 
Group*Interval P vs. E .08 .35 0.22 .83 
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 M vs. E -.75 .35 -2.13 .03* 
Group*Interval*Interval P vs. E -.02 .07 -0.29 .78 
 M vs. E .14 .07 1.99 .047* 
RD*Group*Interval P vs. E -.24 .59 -0.40 .69 
 M vs. E .77 .70 1.10 .27 
RD*Group*Interval 
*Interval 
P vs. E .04 .12 0.34 .73 
 M vs. E -.14 .14 -1.03 .30 
†p<.10  *p<.05  **p<.01  ***p<.001 
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Table 10 
 
Group, interval, and RD effects in the prediction of NA, P vs. M contrast 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .08 .02 3.50 <.001*** 
Residual  .24 .02 11.16 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  .41 .25 1.63 .11 
Between subject (df = 82) 
RD  -1.02 .58 1.76 .08† 
Group P vs. M -.80 .35 -2.29 .02* 
Within subject (df = 249) 
Interval  .90 .22 4.01 <.001*** 
Interval*Interval  -.18 .04 -4.13 <.001*** 
Within & between subject interaction (df = 249) 
RD*Group P vs. M 1.29 .72 1.79 .08† 
RD*Interval  1.20 .52 2.31 .02* 
RD*Interval*Interval -.24 .10 -2.30 .02* 
Group*Interval P vs. M .84 .31 2.69 .008** 
Group*Interval*Interval P vs. M -.16 .06 -2.59 .01* 
RD*Group*Interval  P vs. M -.97 .64 -1.51 .13 
RD*Group*Interval 
*Interval 
P vs. M .18 .13 1.42 .16 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 11 
 
Beta Coefficients (Standard Error) for Analyses Including History of Recurrent Depression (2 or more MDE) 
 
Fixed effects 
Ma Pb Ec 
ß (SE) t p ß (SE) t p ß (SE) t p 
Negative affect          
   Interval .90 (.18) 4.88 <.001*** 1.74 (.25) 7.09 <.001*** 1.59 (.23) 6.88 <.001*** 
   Interval*Interval -.18 (.48) -5.02 <.001*** -.34 (.05) -7.07 <.001*** -.31 (.05) -6.90 <.001*** 
   RD -1.02 (.48) -2.13 .04* .27 (.47) .57 .57 -.36 (.45) -.80 .43 
   RD*Interval 1.20 (.43) 2.81 .006** .23 (.42) .54 .59 .52 (.39) 1.32 .19 
   RD*Interval*Interval -.23 (.08) -2.79 .006** -.05 (.08) -.65 .51 -.10 (.08) -1.28 .20 
Positive affect          
   Interval .90 (.21) 4.38 <.001*** 1.42 (.24) 5.85 <.001*** 1.41 (.28) 5.03 <.001*** 
   Interval*Interval -.19 (.04) -4.73 <.001*** -.30 (.05) -6.31 <.001*** -.28 (.06) -5.00 <.001*** 
   RD .31 (.59) .52 .60 -.07 (.51) -.13 .89 .26 (.56) .46 .65 
   RD*Interval -.49 (.48) -1.02 .31 .02 (.42) .06 .95 -.12 (.48) -.25 .80 
   RD*Interval*Interval .10 (.09) 1.01 .31 -.01 (.08) -.14 .89 -.0003 (.09) .00 .997 
†p<.10  *p<.05  **p<.01  ***p<.001 
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Table 12 
 
Group, interval, and testing effects in the prediction of NA, P vs. E & M vs. E contrasts 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .06 .01 5.26 <.001*** 
Var (1)  .09 .01 6.28 <.001*** 
Var (2)  .42 .06 7.30 <.001*** 
Var (3)  .49 .06 7.52 <.001*** 
Var (4)  .03 .009 3.00 .001** 
ARH (1)  .16 .07 2.18 .03* 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  .37 .61 0.61 .54 
Between subject (df = 125) 
Pre/Post  -.41 .38 -1.09 .28 
Group P vs. E .49 .83 0.59 .56 
 M vs. E .004 .84 0.00 .996 
Within subject (df = 367) 
Interval  .92 .66 1.38 .17 
Interval*Interval  -.20 .13 -1.51 .13 
Within & between subject interaction (df = 367) 
Pre/Post*Group P vs. E -.27 .51 -0.53 .60 
 M vs. E .34 .55 .62 .53 
Pre/Post*Interval .54 .41 1.33 .19 
Pre/Post*Interval*Interval -.10 .08 -1.21 .23 
Group*Interval P vs. E -.75 .90 -0.84 .40 
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 M vs. E -.32 .91 -0.35 .73 
Group*Interval*Interval P vs. E .16 .18 0.93 .35 
 M vs. E .08 .18 0.45 .65 
Pre/Post*Group*Interval P vs. E .48 .56 0.86 .39 
 M vs. E -.19 .60 -0.31 .76 
Pre/Post*Group*Interval
*Interval 
P vs. E -.11 .11 -1.00 .32 
 M vs. E .01 .12 0.17 .87 
†p<.10  *p<.05  **p<.01  ***p<.001 
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Table 13 
 
Group, interval, and testing effects in the prediction of NA, P vs. M contrast 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .08 .02 3.70 <.001*** 
Residual  .23 .02 11.23 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  .15 .66 0.23 .81 
Between subject (df = 85) 
Pre/Post  .05 .45 0.12 .90 
Group P vs. M .83 .92 0.91 .37 
Within subject (df = 250) 
Interval  .74 .59 1.25 .21 
Interval*Interval  -.13 .12 -1.12 .26 
Within & between subject interaction (df = 250) 
Pre/Post*Group P vs. M -.89 .60 0.12 .90 
Pre/Post*Interval .28 .40 0.69 .49 
Pre/Post*Interval* -.07 .08 -0.88 .38 
Group*Interval P vs. M -.66 .82 -0.80 .42 
Group*Interval*Interval P vs. M .11 .26 0.65 .51 
Pre/Post*Group*Interval P vs. M .85 .54 1.58 .12 
Pre/Post*Group*Interval
*Interval 
P vs. M -.15 .11 -1.39 .17 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 14 
 
Beta Coefficients (Standard Error) for Analyses Assessing for Testing Effects 
 
Fixed effects 
Ma Pb Ec 
ß (SE) t p ß (SE) t p ß (SE) t p 
Negative affect          
   Interval .63 (.56) 1.12 .26 .08 (.63) .12 .90 .93 (.61) 1.53 .13 
   Interval*Interval -.12 (.11) -1.10 .27 -.02 (.12) -.20 .84 -.20 (.12) -1.66 .0995† 
   Pre/Post -.06 (.33) -.20 .85 -.83 (.44) -1.90 .06† -.42 (.42) -.99 .33 
   Pre/Post*Interval .34 (.39) .88 .38 1.13 (.39) 2.87 .005** .55 (.37) 1.46 .15 
  Pre/Post*Interval*Interval -.07 (.08) -.96 .34 -.22 (.08) -2.81 .006** -.10 (.07) -1.32 .19 
Positive affect          
   Interval .10 (.55) 1.81 .07† 1.02 (.64) 1.61 .11 2.79 (.73) 3.82 <.001*** 
   Interval*Interval -.22 (.11) -2.05 .04* -.19 (.13) -1.56 .12 -.54 (.14) -3.72 <.001*** 
   Pre/Post .33 (.46) .73 .47 .15 (.47) .32 .75 1.38 (.53) 2.61 .01* 
   Pre/Post*Interval -.16 (.38) -.43 .66 .25 (.39) .64 .52 -.92 (.45) -2.04 .04* 
  Pre/Post*Interval*Interval .04 (.07) .54 .59 -.07 (.08) -.91 .37 .17 (.09) 1.90 .06† 
Note: a dfM = 112, b dfP = 139, c dfE = 118, †p<.10  *p<.05  **p<.01  ***p<.001  
 47 
Table 15 
 
Group and interval effects in the prediction of NA excluding patients who had pre lab, P vs. E & 
M vs. E contrasts 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .11 .03 3.69 <.001*** 
Var (1)  .15 .03 4.22 <.001*** 
Var (2)  .52 .10 4.98 <.001*** 
Var (3)  .61 .12 5.17 <.001*** 
Var (4)  .05 .02 2.28 .01* 
ARH (1)  .21 .11 1.97 .049* 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  -.44 .29 -1.51 .14 
Between subject (df = 60) 
Group P vs. E -.0003 .40 -0.00 .99 
 M vs. E .68 .46 1.46 .15 
Within subject (df = 181) 
Interval  2.00 .31 6.41 <.001*** 
Interval*Interval  -.39 .06 -1.38 <.001*** 
Within & between subject interaction (df =181) 
Group*Interval P vs. E .13 .42 0.30 .76 
 M vs. E -.69 .49 -1.38 .17 
Group*Interval*Interval P vs. E -.04 .08 -0.46 .65 
 M vs. E .12 .10 1.23 .22 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 16 
 
Group and interval effects in the prediction of NA excluding patients who had pre lab, P vs. M 
contrast 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .14 .05 2.69 .004** 
Residual  .33 .04 7.66 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t P 
Intercept  .26 .42 0.62 .54 
Between subject (df = 39) 
Group P vs. M -.94 .53 -1.77 .09† 
Within subject (df = 117) 
Interval  1.30 .38 3.43 <.001*** 
Interval*Interval  -.27 .07 -3.20 <.001*** 
Within & between subject interaction (df = 117) 
Group*Interval P vs. M 1.03 .48 2.17 .03* 
Group*Interval*Interval P vs. M -.19 .09 -2.01 .047* 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 17 
 
Beta Coefficients (Standard Error) for Post-only Analyses by Group 
 
Fixed effects 
Ma (n = 15) Pb (n = 26) Ec (n = 22) 
ß (SE) t ß (SE) t ß (SE) t 
Negative affect       
   Interval 1.30 (.34) 3.84*** 2.33 (.30) 7.67*** 2.02 (.25) 8.14*** 
   Interval*Interval -.27 (.07) -4.05*** -.46 (.06) -7.69*** -.39 (.05) 8.06*** 
Positive affect       
   Interval .68 (.25) 2.73** 1.53 (.28) 5.38*** .94 (.24) 3.87*** 
   Interval*Interval -.14 (.05) -2.91** -.33 (.06) -6.01*** -.20 (.05) -4.14*** 
Note: a dfM = 42, b dfP = 75, c dfE = 64, *p<.05  **p<.01  ***p<.001 
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Table 18 
 
Group and interval effects in the prediction of PA, P vs. E & M vs. E contrasts 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .43 .06 6.78 <.001*** 
Residual  .27 .02 13.70 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  1.35 .25 5.40 <.001*** 
Between subject (df = 125) 
Group P vs. E -.03 .34 -0.08 .94 
 M vs. E .84 .36 2.34 .02* 
Within subject (df = 376) 
Interval  1.37 .21 6.61 <.001*** 
Interval*Interval  -.28 .04 -6.77 <.001*** 
Within & between subject interaction (df = 376) 
Group*Interval P vs. E .05 .28 0.18 .86 
 M vs. E -.60 .30 -2.00 .046* 
Group*Interval*Interval P vs. E -.03 .06 -0.49 .62 
 M vs. E .11 .06 1.88 .06† 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 19 
 
Group and interval effects in the prediction of PA, P vs. M contrast 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .44 .08 5.71 <.001*** 
Residual  .25 .02 11.32 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  2.18 .25 8.86 <.001*** 
Between subject (df = 85) 
Group P vs. M -.86 .33 -2.60 .01* 
Within subject (df = 256) 
Interval  .78 .20 3.82 <.001*** 
Interval*Interval  -.17 .04 -4.18 <.001*** 
Within & between subject interaction (df = 256) 
Group*Interval P vs. M .65 .27 2.37 .02* 
Group*Interval*Interval P vs. M -.14 .05 -2.56 .01* 
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Table 20 
 
Group and interval effects in the prediction of PA covarying NA, P vs. E & M vs. E contrasts 
 
Random effects 
Covariance parameter estimate β SE Z  p 
UN (1,1)  .43 .06 6.80 <.001*** 
Residual  .27 .02 13.65 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  1.38 .48 2.86 .005** 
Between subject (df = 125) 
Group P vs. E .02 .34 0.05 .96 
 M vs. E .82 .35 2.32 .02* 
Within subject (df = 373) 
NA  .09 .34 0.26 .30 
Interval  1.42 .43 3.30 .001** 
Interval*Inteval  -.33 .09 -3.71 <.001*** 
Within & between subject interaction (df = 373) 
NA*Interval -.17 .29 -0.58 .56 
NA*Interval*Interval .06 .06 1.07 .29 
Group*Interval P vs. E .003 .28 0.01 .99 
 M vs. E -.59 .30 -1.99 .048* 
Group*Interval*Interval P vs. E -.02 .05 -0.31 .76 
 M vs. E .11 .06 1.93 .05† 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 21 
 
Group and interval effects in the prediction of PA covarying NA, P vs. M contrast 
 
Random effects 
Covariance parameter estimate β SE Z  p 
UN (1,1)  .44 .08 5.71 <.001*** 
Residual  .24 .02 11.25 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  2.50 .52 4.85 <.001*** 
Between subject (df = 85) 
Group P vs. M -.76 .33 -2.29 .02* 
Within subject (df = 253) 
NA  -.14 .39 -0.37 .71 
Interval  .43 .46 0.94 .35 
Interval*Interval  -.12 .09 -1.25 .21 
Within & between subject interaction (df = 253) 
NA*Interval .15 .34 0.43 .67 
NA*Interval*Interval -.01 .07 -0.17 .86 
Group*Interval P vs. M .53 .28 1.94 .05† 
Group*Interval*Interval P vs. M -.12 .05 -2.16 .03* 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 22 
 
Group, interval, and RD effects in the prediction of PA, P vs. E & M vs. E contrasts 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .44 .07 6.67 <.001*** 
Residual  .28 .02 13.54 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  1.26 .31 4.07 <.001*** 
Between subject (df = 121) 
RD  .26 .53 0.50 .62 
Group P vs. E .09 .42 0.20 .84 
 M vs. E .86 .42 2.04 .04* 
Within subject (df = 367) 
Interval  1.41 .26 5.48 <.001*** 
Interval*Interval  -.28 .05 -5.45 <.001*** 
Within & between subject interaction (df = 367) 
RD*Group P vs. E -.33 .72 -0.46 .65 
 M vs. E .04 .85 0.05 .96 
RD*Interval  -.12 .44 -0.28 .78 
RD*Interval*Interval .0004 .09 0.00 .997 
Group*Interval P vs. E .003 .35 0.01 .99 
 M vs. E -.51 .35 -1.45 .15 
Group*Interval*Interval P vs. E -.02 .07 -0.34 .73 
 M vs. E .09 .07 1.23 .22 
RD*Group*Interval P vs. E .15 .60 0.24 .81 
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 M vs. E -.37 .71 -0.52 .60 
RD*Group*Interval 
*Interval 
P vs. E -.01 .11 -0.10 .92 
 M vs. E .10 .14 0.68 .50 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 23 
 
Group, interval, and RD effects in the prediction of PA, P vs. M contrast 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .45 .08 5.60 <.001*** 
Residual  .25 .02 11.16 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  2.12 .28 7.60 <.001*** 
Between subject (df = 82) 
RD  .31 .65 0.47 .64 
Group P vs. M -.77 .39 -1.98 .051† 
Within subject (df = 249) 
Interval  .90 .23 3.92 <.001*** 
Interval*Interval  -.19 .05 -4.24 <.001*** 
Within & between subject interaction (df = 249) 
RD*Group P vs. M -.38 .80 -0.47 .64 
RD*Interval -.49 .53 -0.92 .36 
RD*Interval*Interval .10 .11 0.91 .36 
Group*Interval  P vs. M .51 .32 1.60 .11 
Group*Interval*Interval P vs. M -.11 .06 -1.72 .09† 
RD*Group*Interval P vs. M .51 .66 0.78 .44 
RD*Group*Interval 
*Interval 
P vs. M -.11 .13 -0.82 .41 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 24 
 
Group, interval, and testing effects in the prediction of PA, P vs. E & M vs. E contrasts 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .42 .06 6.70 <.001*** 
Residual  .27 .02 13.59 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  -.78 .80 -0.97 .33 
Between subject (df = 125) 
Pre/Post  1.39 .50 2.78 .006** 
Group P vs. E 1.89 1.08 1.74 .08† 
 M vs. E 2.50 1.11 2.25 .03* 
Within subject (df = 367) 
Interval  2.80 .67 4.16 <.001*** 
Interval*Interval  -.54 .13 -4.06 <.001*** 
Within & between subject interaction (df = 367) 
Pre/Post*Group P vs. E -1.24 .67 -1.84 .07† 
 M vs. E -1.05 .72 -1.46 .15 
Pre/Post*Interval -.93 .42 -2.23 .03* 
Pre/Post*Interval*Interval .17 .08 2.08 .04* 
Group*Interval P vs. E -1.77 .91 -1.94 .05† 
 M vs. E -1.80 .93 -1.94 .05† 
Group*Interval*Interval P vs. E .34 .18 1.91 .06† 
 M vs. E .32 .18 1.73 .08† 
Pre/Post*Group*Interval P vs. E 1.18 .57 2.09 .04* 
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 M vs. E .76 .60 1.27 .21 
Pre/Post*Group*Interval
*Interval 
P vs. E -.24 .11 -2.16 .03* 
 M vs. E -.13 .12 -1.09 .28 
†p<.10  *p<.05  **p<.01  ***p<.001 
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Table 25 
 
Group, interval, and testing effects in the prediction of PA, P vs. M contrast 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .44 .08 5.64 <.001*** 
Residual  .25 .02 11.23 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  1.72 .74 2.32 .02* 
Between subject (df = 85) 
Pre/Post  .33 .51 0.66 .51 
Group P vs. M -.62 1.02 -0.60 .55 
Within subject (df = 250) 
Interval  1.00 .61 1.63 .10 
Interval*Interval  -.22 .12 -1.84 .07† 
Within & between subject interaction (df = 250) 
Pre/Post*Group P vs. M -.19 .67 -0.28 .78 
Pre/Post*Interval -.16 .42 -0.39 .70 
Pre/Post*Interval*Interval .04 .08 0.49 .63 
Group*Interval P vs. M .02 .85 0.03 .98 
Group*Interval*Interval P vs. M .03 .17 0.17 .87 
Pre/Post*Group*Interval P vs. M .42 .56 0.75 .46 
Pre/Post*Group*Interval
*Interval 
P vs. M -.11 .11 -1.01 .32 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 26 
 
Group and interval effects in the prediction of PA excluding patients who had pre lab, P vs. E & 
M vs. E contrasts 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .43 .09 4.79 <.001*** 
Residual  .24 .02 9.52 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  1.99 .32 6.21 <.001*** 
Between subject (df = 60) 
Group P vs. E -.59 .44 -1.34 .18 
 M vs. E .40 .50 0.80 .43 
Within subject (df = 181) 
Interval  .94 .26 3.59 <.001*** 
Interval*Interval  -.20 .05 -3.84 <.001*** 
Within & between subject interaction (df =181) 
Group*Interval P vs. E .58 .36 1.62 .11 
 M vs. E -.27 .42 -0.65 .52 
Group*Interval*Interval P vs. E -.14 .07 -1.93 .06† 
 M vs. E .06 .08 0.69 .49 
†p<.10  *p<.05  **p<.01  ***p<.001
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Table 27 
 
Group and interval effects in the prediction of PA excluding patients who had pre lab, P vs. M 
contrast 
 
Random effects 
Covariance parameter estimate β SE Z p 
UN (1,1)  .44 .11 3.85 <.001*** 
Residual  .25 .03 7.65 <.001*** 
Fixed effects 
Predictor variable Contrast β SE t p 
Intercept  2.39 .40 6.95 <.001*** 
Between subject (df = 39) 
Group P vs. M -.99 .51 -1.95 .06† 
Within subject (df = 117) 
Interval  .68 .33 2.03 .045* 
Interval*Interval  -.14 .07 -2.16 .03* 
Within & between subject interaction (df = 117) 
Group*Interval P vs. M .85 .42 2.03 .04* 
Group*Interval*Interval P vs. M -.19 .08 -2.33 .02* 
†p<.10  *p<.05  **p<.01  ***p<.001 
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